![Michael E. Bozik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael E. Bozik
Corporate Officer/Principal bij BIOHAVEN LTD.
Actieve functies van Michael E. Bozik
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BIOHAVEN LTD. | Corporate Officer/Principal | - | - |
Knopp Neurosciences, Inc.
![]() Knopp Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Knopp Neurosciences, Inc. operates as a drug discovery and development company. It focused on delivering breakthrough treatments in neurological disorders. It operates through three areas: inflammation discovery platform, mitochondrial discovery platform, and ion channel discovery platform. The company was founded by Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | - | - | |
President | - | - | |
Knopp Biosciences LLC
![]() Knopp Biosciences LLC Pharmaceuticals: MajorHealth Technology Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Directeur/Bestuurslid | 28-12-2010 | - |
Algemeen Directeur | 28-12-2010 | - | |
President | 28-12-2010 | - | |
Life Sciences Pennsylvania
![]() Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Directeur/Bestuurslid | - | - |
Channel Biosciences LLC
![]() Channel Biosciences LLC BiotechnologyHealth Technology Part of Pfizer Inc., Channel Biosciences LLC is an American bioscience company. The company is located in the US. The CEO of the company is Michael E. Bozik. Channel Biosciences was acquired by Biohaven Pharmaceutical Holding Co. Ltd., a subsidiary of Pfizer Inc. from Knopp Biosciences LLC on April 01, 2022 for $1,230.99 million. | Algemeen Directeur | - | - |
Areteia Therapeutics, Inc.
![]() Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Directeur/Bestuurslid | - | - |
Loopbaan van Michael E. Bozik
Eerdere bekende functies van Michael E. Bozik
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
UPMC Cancer Institute
![]() UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Corporate Officer/Principal | 13-07-2009 | - |
Bayer Healthcare LLC
![]() Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Corporate Officer/Principal | - | - |
Opleiding van Michael E. Bozik
University of Notre Dame | Undergraduate Degree |
University of Pittsburgh | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Sectoraal
Health Technology | 8 |
Consumer Services | 3 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIOHAVEN LTD. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Knopp Neurosciences, Inc.
![]() Knopp Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Knopp Neurosciences, Inc. operates as a drug discovery and development company. It focused on delivering breakthrough treatments in neurological disorders. It operates through three areas: inflammation discovery platform, mitochondrial discovery platform, and ion channel discovery platform. The company was founded by Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Bayer Healthcare LLC
![]() Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. | Health Technology |
UPMC Cancer Institute
![]() UPMC Cancer Institute Medical/Nursing ServicesHealth Services UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA. | Health Services |
Knopp Biosciences LLC
![]() Knopp Biosciences LLC Pharmaceuticals: MajorHealth Technology Knopp Biosciences LLC engages in the operation of a drug discovery and development company. It offers dexpramipexole product, an orally bioavaliable small molecule in development treatment of asthma, eosinophil-associated disorders and amyotrophic lateral sclerosis (ALS) disease. The company was founded by Robert Bowser and Gregory T. Hebrank in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Life Sciences Pennsylvania
![]() Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Channel Biosciences LLC
![]() Channel Biosciences LLC BiotechnologyHealth Technology Part of Pfizer Inc., Channel Biosciences LLC is an American bioscience company. The company is located in the US. The CEO of the company is Michael E. Bozik. Channel Biosciences was acquired by Biohaven Pharmaceutical Holding Co. Ltd., a subsidiary of Pfizer Inc. from Knopp Biosciences LLC on April 01, 2022 for $1,230.99 million. | Health Technology |
Areteia Therapeutics, Inc.
![]() Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Health Technology |
- Beurs
- Insiders
- Michael E. Bozik
- Ervaring